"Bence Jones Protein" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An abnormal protein with unusual thermosolubility characteristics that is found in the urine of patients with MULTIPLE MYELOMA.
Descriptor ID |
D001536
|
MeSH Number(s) |
D12.776.124.486.485.900.120 D12.776.124.790.651.900.120 D12.776.377.715.548.900.120
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bence Jones Protein".
Below are MeSH descriptors whose meaning is more specific than "Bence Jones Protein".
This graph shows the total number of publications written about "Bence Jones Protein" by people in this website by year, and whether "Bence Jones Protein" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2001 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bence Jones Protein" by people in Profiles.
-
Uniform response criteria in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. Semin Oncol. 2003 Apr; 30(2):127-31.
-
Urinary beta2-microglobulin masquerading as a Bence Jones protein. Arch Pathol Lab Med. 2001 Apr; 125(4):555-7.
-
Clinical course of solitary extramedullary plasmacytoma. Radiother Oncol. 1999 Sep; 52(3):245-9.
-
Solitary bone plasmacytoma: outcome and prognostic factors following radiotherapy. Int J Radiat Oncol Biol Phys. 1998 Jul 15; 41(5):1063-7.
-
Prognostic features of asymptomatic multiple myeloma. Br J Haematol. 1997 Jun; 97(4):810-4.
-
Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol. 1994 Oct; 53(4):207-12.
-
Leukocyte interferon-induced tumor regression in human metastatic breast cancer, multiple myeloma, and malignant lymphoma. Ann Intern Med. 1980 Sep; 93(3):399-406.
-
Familial paraproteinemia. Arch Intern Med. 1971 Sep; 128(3):427-31.
-
Renal complications in multiple myeloma: pathophysiology and some aspects of clinical management. J Chronic Dis. 1971 Jul; 24(4):221-7.
-
A method for preparing specific fluorescein-conjugated antibody reagents using bentonite immunoadsorents. J Immunol. 1970 Nov; 105(5):1151-61.